These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 445324)

  • 1. Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy.
    Ali NO; Janes WO
    Cancer; 1979 Apr; 43(4):1211-5. PubMed ID: 445324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy in the treatment of Hodgkin's disease.
    Canellos GP; Come SE; Skarin AT
    Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary toxicity secondary to procarbazine.
    Mahmood T; Mudad R
    Am J Clin Oncol; 2002 Apr; 25(2):187-8. PubMed ID: 11943900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrhagic cystitis with MOPP therapy.
    Royal JE; Seeler RA
    Cancer; 1978 Apr; 41(4):1261-4. PubMed ID: 638990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
    Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
    J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recently recognized complications of cancer chemotherapy.
    Arseneau JC; Canellos GP; DeVita VT; Sherins RJ
    Ann N Y Acad Sci; 1974; 230():481-8. PubMed ID: 4595953
    [No Abstract]   [Full Text] [Related]  

  • 7. Patterns of changes in peripheral blood composition in the course of combination chemotherapy of cancer.
    Jedrzejczak WW; Siekierzyński M; Czarnecki C; Dziuk E
    Strahlentherapie; 1976 Nov; 152(5):469-76. PubMed ID: 996891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second malignancy complicating Hodgkin's disease.
    Tawil E; Mercier JP
    J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of Hodgkin's disease].
    Amiel JL; Mathé G
    Rev Prat; 1974 Oct; 24(45):3957-60, 3963-4, 3967-8. PubMed ID: 4141118
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute myeloid leukemia after treatment of Hodgkin's disease].
    Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease?
    Poleksic S; Yeung KY
    Cancer; 1978 Jan; 41(1):12-6. PubMed ID: 626922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.
    Farney RJ; Morris AH; Armstrong JD; Hammer S
    Am Rev Respir Dis; 1977 Jan; 115(1):135-45. PubMed ID: 835882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
    Petru E; Schmähl D
    Neoplasma; 1991; 38(2):147-55. PubMed ID: 2041574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cunningham J; Mauch P; Rosenthal DS; Canellos GP
    Cancer Treat Rep; 1982 Apr; 66(4):1015-22. PubMed ID: 7074629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute leukemia in patients treated for Hodgkin's disease].
    Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
    Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
    Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteonecrosis of the jaws: a complication of cancer chemotherapy.
    Schwartz HC
    Head Neck Surg; 1982; 4(3):251-3. PubMed ID: 6896046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.